Ireland Drops Cautionary Stance On Repeated Biosimilar Switching
Theoretical Immunogenicity Concerns Not Borne Out By Data
Ireland’s Health Products Regulatory Authority has updated its 2015 biosimilars guideline for healthcare professionals. Since that time the use of biosimilars across the EU has grown considerably and more data on their use is available.
